A

AIM

Aim Immunotech

8.90

-0.67-7.04%
After Hours: 9.11  +0.21  +2.36%18:41 06/27 EDT

Financial Statements

Statement:

Key indicator

Income Statement

Balance Sheet

Cash Flow

Reporting Period:

Accumulated Report

FY

YoY:
FY: Financial Year Annual Report
Q: Quarter is quarterly reports. Q1, Q2, Q3 and Q4 are reports for a single quarter. Q6 and Q9 are accumulated quarterly reports, respectively contain 6 months' reports and 9 months' report.
Item
FY 2024
FY 2023
FY 2022
FY 2021
FY 2020
Total Revenue

170.00K

202.00K

141.00K

135.00K

163.00K

Revenue

170.00K

202.00K

141.00K

135.00K

163.00K

Other Revenue, Total

--

--

--

--

--

Cost of Revenue, Total

31.00K

42.00K

0

850.00K

806.00K

Gross Profit

139.00K

160.00K

141.00K

-715.00K

-643.00K

Operating Expense

19.91M

32.08M

20.06M

20.82M

14.37M

Selling/General/Admin.Expenses,Total

14.16M

21.64M

13.07M

8.67M

8.65M

Research & Development

5.75M

10.44M

6.99M

7.67M

5.72M

Depreciation/Amortization

--

--

--

--

--

Interest Exp.(Inc.), Net-Operating, Total

--

--

--

--

--

Unusual Expense (Income)

--

--

0

4.48M

-7.00K

Other Operating Expenses, Total

--

--

--

--

--

Operating Income

-19.77M

-31.92M

-19.92M

-21.54M

-15.01M

Interest Inc.(Exp.),Net-Non-Op.,Total

4.06M

1.27M

-1.05M

-268.00K

-453.00K

Gain(Loss) on Sale of Assets

-1.60M

1.69M

1.49M

2.54M

1.19M

Other, Net

--

--

35.00K

145.00K

-123.00K

Net Income Before Taxes

-17.32M

-28.96M

-19.45M

-19.13M

-14.40M

Provision for Income Taxes

--

--

--

--

--

Net Income After Taxes

-17.32M

-28.96M

-19.45M

-19.13M

-14.40M

Minority Interest

--

--

--

--

--

Equity in Affiliates

--

--

--

--

--

U.S. GAAP Adjustment

--

--

--

--

--

Net Income Before Extra. Items

-17.32M

-28.96M

-19.45M

-19.13M

-14.40M

Total Extraordinary Items

--

--

--

--

--

Net Income

-17.32M

-28.96M

-19.45M

-19.13M

-14.40M

Total Adjustments to Net Income

--

--

--

--

--

Income Available to Com Excl ExtraOrd

-17.32M

-28.96M

-19.45M

-19.13M

-14.40M

Income Available to Com Incl ExtraOrd

-17.32M

-28.96M

-19.45M

-19.13M

-14.40M

Dilution Adjustment

--

--

--

--

--

Diluted Net Income

-17.32M

-28.96M

-19.45M

-19.13M

-14.40M

Diluted Weighted Average Shares

560.17K

485.85K

480.47K

473.40K

318.43K

Diluted EPS Excluding ExtraOrd Items

-30.91926

-59.6105

-40.47055

-40.40349

-45.22216

Diluted EPS including ExtraOrd Items

-30.919185

-59.610991

-40.470789

-40.403464

-45.22187

DPS – Common Stock Primary Issue

--

--

--

--

--

Diluted Normalized EPS

-27.97015

-63.0498

-43.5779

-36.29491

-48.4725